Rifaximin for Prevention of Travellers' Diarrhea
Rifaximin for Prevention of Travellers' Diarrhea
The purpose of this study is to determine if 600 mg of rifaximin, taken once a day for 14
 days by healthy subjects, is safe and effective for the prevention of travellers' diarrhea
 compared to placebo.
To determine if 600 mg of rifaximin, taken once a day for 14 days by healthy subjects, is
 safe and effective for the prevention of travellers' diarrhea compared to placebo.
Inclusion Criteria:

 1. travelling to Mexico within 72 hours of enrollment

 2. read and understand English

 3. in good health

 Exclusion Criteria:

 1. acute diarrhea within previous 7 days

 2. taken FQs (any drug in this class), macrolide, azalide, or
 trimethoprim-sulfamethoxazole within 7 days or enrollment or anytime during study.

 3. taken antidiarrheal medication within 24 hours of enrollment or anytime during study.